Dermatitis herpetiformis (DH) is the skin manifestation of celiac disease, presenting with a blistering rash typically on the knees, elbows, buttocks and scalp. In both DH and celiac disease, exposure to dietary gluten triggers a cascade of events resulting in the production of autoantibodies against the transglutaminase (TG) enzyme, mainly TG2 but often also TG3. The latter is considered to be the primary autoantigen in DH. The dynamics of the development of the TG2-targeted autoimmune response have been studied in depth in celiac disease, but the immunological process underlying DH pathophysiology is incompletely understood. Part of this process is the occurrence of granular deposits of IgA and TG3 in the perilesional skin. While this serves as the primary diagnostic finding in DH, the role of these immunocomplexes in the pathogenesis is unknown. Intriguingly, even though gluten-intolerance likely develops initially in a similar manner in both DH and celiac disease, after the onset of the disease, its manifestations differ widely.
17 October 2025 in Journal of Investigative Dermatology
Dermatitis herpetiformis (DH) is a dietary gluten -induced autoimmune blistering skin disease. It is hypothesized to be initiated by a small intestinal mucosal immune response. Gluten-free diet (GFD) is the primary treatment for DHdermatitis herpetiformis and effectively resolves skin lesions. Previous studies show that after gluten reintroduction, peripheral cell responses are detectable already in six6 days, and most patients relapse clinically within months. The relapse presentation may differ between patients, with some experiencing both rash and small intestinal mucosal damage and some only one of these. Here, RNA transcriptomics were utilized to characterize temporal systemic and small intestinal mucosal responses to gluten in DH,dermatitis herpetiformis and to identify transcriptomic profiles specific for rash or villous atrophy as relapse presentations. The cohort consisted of 19 DHdermatitis herpetiformis patients on GFDgluten-free diet who underwent a gluten challenge. Gluten challenge elicited pronounced gene expression changes related to inflammation in the small intestine. In patients relapsing with rash, DOCK8 expression was significantly upregulated, while IL10RB was downregulated at end of follow-up. These patients also had significantly increased frequency of intraepithelial lymphocytes. Our findings show that prolonged gluten exposure alters duodenal transcriptomic profiles considerably. Moreover, patterns related to rash could be detected and present interesting candidates for future studies.
Background and aims: Celiac disease is a wheat-induced immune-mediated enteropathy characterized by cytokine, especially IFNg upregulation. Intestinal organoid models for adult stem cell based celiac disease exist, but planar iPSC based small intestinal epithelial models derived from celiac disease patients that would allow direct assessment from both sides of the epithelium have been lacking. We aimed to bridge this gap by setting up a two-dimensional in vitro model based on small intestinal epithelial cells derived from iPSC from celiac disease patient. Methods: IPSCs from celiac disease patient and control patient were directly differentiated into small intestinal epithelium on Transwell inserts without intermediate organoid phase or replating. Model maturity and celiac disease specific cytokine responses were analysed using immunofluorescence, transcriptomic profiling, and LDH cytotoxicity assay. Results: Two-dimensionally cultured celiac disease derived line and control patient derived iPSCs matured similarly towards intestinal epithelium which expressed enterocyte specific PEPT1 and EpCAM. To the cytokine stimuli, celiac and healthy iPSC-SIECs responded by increasing the expression IRF1, ICAM1 and IDO1, and several other known cytokine responsive genes. Conclusions: These findings suggest that the 2D iPSC celiac disease small intestinal epithelium model represent an appropriate platform for studying inflammation-associated enteropathies, such as celiac disease.